O. Y. Lee

777 total citations
9 papers, 622 citations indexed

About

O. Y. Lee is a scholar working on Gastroenterology, Surgery and Epidemiology. According to data from OpenAlex, O. Y. Lee has authored 9 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Gastroenterology, 5 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in O. Y. Lee's work include Gastrointestinal motility and disorders (7 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Gastroesophageal reflux and treatments (2 papers). O. Y. Lee is often cited by papers focused on Gastrointestinal motility and disorders (7 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Gastroesophageal reflux and treatments (2 papers). O. Y. Lee collaborates with scholars based in South Korea, Mexico and Australia. O. Y. Lee's co-authors include Max J. Schmulson, Emeran Mayer, Lin Chang, Young‐Tae Bak, J. A. Jones, Amy W. Wagner, Satawat Thongsawat, John Kellow, Hok Pan Yuen and M Z Mazlam and has published in prestigious journals such as Gut, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

O. Y. Lee

9 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Y. Lee South Korea	8	529	272	186	81	66	9	622
Patrick P.J. van der Veek Netherlands	10	449 0.8×	156 0.6×	117 0.6×	66 0.8×	64 1.0×	12	544
Mopelola Adeyemo United States	8	396 0.7×	197 0.7×	140 0.8×	68 0.8×	32 0.5×	11	576
Mario Vassallo United States	12	643 1.2×	413 1.5×	160 0.9×	81 1.0×	56 0.8×	21	849
Priya Oka United Kingdom	4	444 0.8×	146 0.5×	119 0.6×	60 0.7×	69 1.0×	4	544
P. Rüegg Switzerland	4	653 1.2×	360 1.3×	210 1.1×	104 1.3×	112 1.7×	9	731
G. Staumont France	14	349 0.7×	445 1.6×	131 0.7×	53 0.7×	54 0.8×	36	726
Michael Camilleri United States	5	734 1.4×	505 1.9×	156 0.8×	80 1.0×	46 0.7×	6	869
Baha Moshiree United States	9	524 1.0×	238 0.9×	146 0.8×	81 1.0×	77 1.2×	26	706
Brigitte Nault Switzerland	5	726 1.4×	450 1.7×	197 1.1×	97 1.2×	81 1.2×	8	781
F. Tremolaterra Italy	12	353 0.7×	209 0.8×	119 0.6×	59 0.7×	30 0.5×	21	545

Countries citing papers authored by O. Y. Lee

Since Specialization

Citations

This map shows the geographic impact of O. Y. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Y. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Y. Lee more than expected).

Fields of papers citing papers by O. Y. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Y. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Y. Lee. The network helps show where O. Y. Lee may publish in the future.

Co-authorship network of co-authors of O. Y. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of O. Y. Lee. A scholar is included among the top collaborators of O. Y. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Y. Lee. O. Y. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Shin, Cheol Min, Suck Chei Choi, Jin–Woong Cho, et al.. (2024). Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi‐Center, Randomized, Double‐Blind, Active‐Comparator Phase 4 Trial. Neurogastroenterology & Motility. 37(1). e14969–e14969. 5 indexed citations

Bashashati, Mohammad, Shirin Moossavi, Cesare Cremon, et al.. (2017). Colonic immune cells in irritable bowel syndrome: A systematic review and meta‐analysis. Neurogastroenterology & Motility. 30(1). 135 indexed citations

Choi, Chang Hwan, Joong Goo Kwon, Seung‐Jae Myung, et al.. (2015). Efficacy of combination therapy with probiotics and mosapride in patients withIBSwithout diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial. Neurogastroenterology & Motility. 27(5). 705–716. 37 indexed citations

Sohn, Won, et al.. (2012). Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open‐label, non‐inferiority, randomized controlled study. Neurogastroenterology & Motility. 24(9). 860–860. 19 indexed citations

Jun, Dae Won, et al.. (2012). Carbohydrate but not fat is associated with elevated aminotransferases. Alimentary Pharmacology & Therapeutics. 35(9). 1064–1072. 20 indexed citations

Huh, Kyu Chan, O. Y. Lee, Suck Chei Choi, et al.. (2011). Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. Neurogastroenterology & Motility. 23(12). 1098–1104. 56 indexed citations

Kellow, John, O. Y. Lee, F. Y. Chang, et al.. (2003). An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut. 52(5). 671–676. 191 indexed citations

Chang, Lin, et al.. (2001). Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. The American Journal of Gastroenterology. 96(12). 3341–3347. 149 indexed citations

Lee, O. Y., Max Schmulson, & Emeran A. Mayer. (1999). Common functional gastrointestinal disorders: Nonulcer dyspepsia and irritable bowel syndrome. Clinical cornerstone. 1(5). 57–71. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact